A phase 2 study of modified lenalidomide, bortezomib and dexamethasone in transplant ‐ineligible multiple myeloma

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - May 9, 2018 Category: Hematology Authors: Elizabeth K. O'Donnell , Jacob P. Laubach , Andrew J. Yee , Tianqi Chen , Carol Ann Huff , Frank G. Basile , Philip M. Wade , Claudia E. Paba ‐Prada , Irene M. Ghobrial , Robert L. Schlossman , Jill N. Burke , Cynthia C. Harrington Source Type: research